Partnering & Outsourcing Editorial

  1. No CRO? No Problem As Curadev Tackles Site Selection For Its First Clinical Trial 3/21/2024

    Curadev COO and CFO Manish Tandon discusses the company's first foray into site selection (all without a CRO), covering a site’s influence on patient recruitment and centricity.

  2. Why The 'Illusion' Of Speed In Clinical Trials Unravels As Contracting Demands Scale 3/19/2024

    Discover four mistakes biotechs often make in haste (and how to avoid them) as they hurry through clinical trial contracting on the path to commercilization.

  3. A Better Recipe For Sourcing Your Clinical Trial 3/14/2024

    Is outsourcing still the optimal pathway for conducting clinical trials in the 21st century? A better recipe for success might include insourcing and functional service providers (FSP), sprinkled with a handful of outsourced tasks, for a more stress-free and agile clinical trial experience.

  4. Channel Your Inner Child To Become A Better Clinical Research Professional 2/28/2024

    Sites, CROs, and sponsors sometimes have contentious relationships. It doesn't have to be that way. Discover how to leverage The Zones of Regulation to better manage emotions and become a better partner and CRP.

  5. Donating Surplus Clinical Trial Supplies Is Sustainability's “Low-Hanging Fruit” 1/29/2024

    ClinOps professionals know all too well the waste that occurs with leftover trial kits that are destroyed at the end of the trial. Explore donation as a way to give those kits a second life.

  6. When A Rare Disease Partnership Evolves Into A Global Effort 12/21/2023

    Marked by a gradual evolution from small, meeting-oriented work to a transformative initiative, the FSHD Society and Fulcrum Therapeutics partnership in rare disease research exemplifies the power of trust and shared commitment.

  7. Trip Or No Trip: Pharmas Are Taking Psychedelic Trials To Australia 12/13/2023

    Enveric Biosciences CEO Joseph Tucker, Ph.D., chronicles the company's quest for regulatory approval in Australia, as well as navigates the unknowns of developing psychedelics for therapeutic use.

  8. Outsourcing And Phase-Appropriate GMP For Clinical Manufacturing Needs 11/20/2023

    Appropriate manufacturing and timely delivery of investigational products are essential for the successful execution of clinical trials. This article shares best practices working with CDMOs as well as phase-appropriate GMP of the clinical supply.

  9. In Search Of The Unicorn: Do End-To-End C(x)DMOs Really Exist? 11/8/2023

    Over the years, we have seen the progression of the biologics contract services go from contract manufacturing organizations (CMO) to what this expert today calls the C(x)DMO: the contract analytical/research/testing development manufacturing organization. Focusing on the mammalian biologics segment, this expert analyzed public information and a proprietary database by looking at 80 service providers supporting projects ranging from early discovery to commercial manufacturing. 

  10. Identifying & Enabling Innovative Partnerships With Reeve Foundation CEO Maggie Goldberg 10/16/2023

    CEO Maggie Goldberg discusses the Reeve Foundation’s partnership approach — from how partners are identified to what each sector brings to the field of SCI to how partnerships are evaluated for effectiveness.